+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form and End User

  • PDF Icon

    Report

  • 130 Pages
  • July 2022
  • Region: Global
  • The Insight Partners
  • ID: 5646842
UP TO OFF until Jan 15th 2023
The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live micro-organisms that promote good digestive health and help to improve human gut health. They play a vital role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Gut health has become one of the prime health concerns among consumers. Increasing awareness regarding the benefits of probiotics has surged their popularity in infant, child, and maternal women health supplements. These factors are significantly driving the demand for these supplements across the world. There is a rising prevalence of digestive disorders due to unhealthy consumption habits amongst children. This factor provides a strong potential to the infant, child, and maternal probiotic supplements market.

Based on end use, the infant, child, and maternal probiotic supplements market is segmented into infant and toddler, children, and maternal women. The children segment accounted for the largest market share in 2020. However, the maternal women segment is expected to register the highest CAGR during the forecast period.

Probiotic supplements are gaining popularity among pregnant women due to their role in reducing the risk of eczema in babies, lessening complications associated with childbirth, and improving the metabolic health of expectant mothers. Women experience dramatic changes in physiology and immune systems during pregnancy, including alterations in the gut microbiome population. These issues can be addressed using probiotic supplements. Probiotic supplements help pregnant women gain weight.

Based on region, the infant, child, and maternal probiotic supplements market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2020, North America held the largest market share. Asia Pacific is estimated to register the fastest CAGR over the forecast period. The dominance of North America is attributed to the increasing awareness among consumers about the benefits of probiotic supplements for infants, children, and pregnant women. Parents in the region are more concerned about their children's development and growth.

Some common health conditions observed in the region include allergies, asthma, urinary tract infection, colic in infants, and autism. According to the Allergy & Asthma Foundation of Asthma, in 2018, approximately 5.2 thousand children in the US were diagnosed with seasonal allergic rhinitis. Increasing health issues among children have concerned parents, which in turn, has resulted in the rising uptake of probiotic supplements.

Moreover, governments of North American countries are taking initiatives to improve infant and children's health. For instance, Healthy Start is one initiative to improve childhood health care. This initiative is designed to reduce the infant mortality rate and improve prenatal health in the region. Hence, the prenatal and postnatal use of probiotic supplements is further surging the growth of the infant, child, and maternal probiotic supplements market across North America.

The key players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy's Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are focusing on new product launches and geographical expansions to meet the growing consumer demand worldwide.

The overall infant, child, and maternal probiotic supplements market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders, specializing in the Infant, Child, and Maternal Probiotic Supplements Market.

Frequently Asked Questions about the Global Infant, Child, and Maternal Probiotic Supplements Market

What is the estimated value of the Global Infant, Child, and Maternal Probiotic Supplements Market?

The Global Infant, Child, and Maternal Probiotic Supplements Market was estimated to be valued at $604.94 million in 2022.

What is the growth rate of the Global Infant, Child, and Maternal Probiotic Supplements Market?

The growth rate of the Global Infant, Child, and Maternal Probiotic Supplements Market is 8.7%, with an estimated value of $1081.7 million by 2028.

What is the forecasted size of the Global Infant, Child, and Maternal Probiotic Supplements Market?

The Global Infant, Child, and Maternal Probiotic Supplements Market is estimated to be worth $1081.7 million by 2028.

Who are the key companies in the Global Infant, Child, and Maternal Probiotic Supplements Market?

Key companies in the Global Infant, Child, and Maternal Probiotic Supplements Market include Bayer Corporation, Nestle S.A., Mommy’s Bliss Inc., LoveBug Probiotics, Biogaia AB, MaryRuth Organics, LLC, Pharmavite LLC, Evolve Biosystems and Nordic Naturals.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
3.2.8 Limitations and Assumptions:
4. Infant, Child, and Maternal Probiotic Supplements Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis
5. Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
5.3 Market Opportunities
5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints
6. Infant, Child, and Maternal Probiotic Supplements - Global Market Analysis
6.1 Infant, Child, and Maternal Probiotic Supplements Market Overview
6.2 Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
6.3 Competitive Positioning - Key Market Players
7. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form
7.1 Overview
7.2 Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
7.3.1 Overview
7.3.2 Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
7.4.1 Overview
7.4.2 Gummies: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
7.5.1 Overview
7.5.2 Liquid: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others: Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)
8. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User
8.1 Overview
8.2 Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
8.3.1 Overview
8.3.2 Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
8.4.1 Overview
8.4.2 Children: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
8.5.1 Overview
8.5.2 Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9. Infant, Child, and Maternal Probiotic Supplements Market - Geographic Analysis
9.1 Overview
9.2 North America: Infant, Child, and Maternal Probiotic Supplements Market
9.2.1 North America: Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
9.2.2 North America: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.3 North America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.2.4 North America: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.2.4.1 US: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.2.4.1.1 US: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.4.1.2 US: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.2.4.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.2.4.2.1 Canada: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.4.2.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.2.4.3 Mexico: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.2.4.3.1 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.4.3.2 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market
9.3.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
9.3.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.3.4.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.2 UK: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.3 France: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.4 Italy: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.5 Russia: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.6 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market
9.4.1 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.4.2 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.3 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.4.4.1 China: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.1.1 China: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.1.2 China: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.2.1 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.2.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.3 Australia: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.3.1 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.3.2 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.4 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.4.1 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.4.2 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.5 Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.5.1 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.5.2 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market
9.5.1 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.5.2 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.5.3 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5.4 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Key Region
9.5.4.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.5.4.1.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.5.4.1.2 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5.4.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
9.5.4.2.1 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.5.4.2.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by End User
10. Industry Landscape
10.1 Overview
10.2 Product launch
10.3 Expansion
11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market
11.1 Impact of COVID-19 on Infant, Child, and Maternal Probiotic Supplements Market
11.2 North America: Impact Assessment of COVID-19 Pandemic
11.3 Europe Impact Assessment of COVID-19 Pandemic
11.4 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.6 South & Central America: Impact Assessment of COVID-19 Pandemic
12. COMPANY PROFILES
12.1 Bayer Corporation
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MaryRuth Organics, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Mommy’s Bliss Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pharmavite LLC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nestlé S.A.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BioGaia AB
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Evolve Biosystems
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lovebug Probiotics
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Biomeology
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Nordic Naturals
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Word Index

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer Corporation
  • Nestle S.A.
  • Mommy’s Bliss Inc.
  • LoveBug Probiotics
  • Biogaia AB
  • MaryRuth Organics, LLC
  • Pharmavite LLC
  • Evolve Biosystems
  • Biomeology
  • Nordic Naturals